Cellectar Biosciences, Inc.
CLRBW
CLRBW was delisted on the 20th of August, 2019.
3 hedge funds and large institutions have $201K invested in Cellectar Biosciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
19% less capital invested
Capital invested by funds: $248K → $201K (-$47K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$392 |
CLRBW Hedge Fund Activity: Q3 2016 in Review
3 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q3 2016, worth a combined $201K — down 19% from $248K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CLRBW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, cutting an estimated $392.
- 3 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q3 2016, down from 4 in Q2 2016.
- Funds reported $201K of Cellectar Biosciences, Inc. stock for Q3 2016, down 19% quarter-over-quarter.
- 0 funds opened new Cellectar Biosciences, Inc. positions in Q3 2016 and 1 closed out, a net change of -1 holder.
- The largest Cellectar Biosciences, Inc. seller in Q3 2016 was Sabby Management, an estimated $392 sold.
Based on aggregated 13F filings for Q3 2016.